Product Images Byetta

This is a chart showing the insulin response in patients with Type 2 Diabetes who received an IV infusion of insulin, followed by either BYETTA or saline for 6.5 hours prior to an IV bolus of glucose. The chart shows glucose levels over time for the three groups of patients: BYETTA-treated Type 2 Diabetics, saline-treated Type 2 Diabetics, and saline-treated healthy patients. The study aimed to evaluate the effects of the different treatments on insulin response.*

This text describes a study or experiment involving a injection called "350 SC Injection". A standardized breakfast was likely given to the participants. The rest of the text consists of numerical data and a graph showing "BYETTAN" and "Placebo" on a time scale in minutes. Mean dose administered was 7.8 mog based on body weight via subcutaneous injection.*

This is a medical report that shows the measurements of Plasma Glucose and Serum Insulin levels in mg/dL and 4U/mL respectively over time (in hours). The report also mentions the administration of BYETTA and Placebo based on the participant's body weight.*

This appears to be a set of instructions related to a medical injection device. It specifies different states the device can be in and what actions can be taken in each state. It mentions a dose knob and injection of 5 mg, but does not provide any specific details on what medication is being administered. The inclusion of "Pen Needles Not Included" suggests that this may be a disposable device that requires separate needles to be attached.*

This is a medication for subcutaneous use only, which contains 60 doses of 10mg each. It should be refrigerated and not frozen. The medication cannot be transferred to a syringe, and pen needles are not included. The user should consult their healthcare provider regarding the appropriate needle size and gauge to use, and it is recommended to use disposable pen needles with 28, 30, or 31 gauge. The medication is called Revazeoccs®.*

This is a medication label for DG aat0-6812.01 which contains medication to be dispensed to patients. The medication contains 250 mg/mL and comes in a 12 mL package. Each prefilled pen contains 60 doses of the medication and is meant for subcutaneous use only. It should be refrigerated and not frozen. The medication should not be transferred to a syringe. The medication label mentions that the pen needles are not included and advises patients to consult their healthcare provider to determine the best length and gauge of a disposable pen needle. The recommended pen needle gauges are 23 (i), 30, or 31 (thinner).*

This is a list of parts for a BYETTA pen used for injecting medication. It includes a blue pen cap, cartridge, BYETTA label, dose window, dose knob, and injection button.*

This is a description of the parts of a pen needle, excluding the pen needles themselves. The parts include an outer needle, inner needle, needle shield, and paper tab. The text also mentions symbols on a dose window that indicate when the dose knob is ready to be pulled out, ready to be turned to the dose position, and when it is ready to inject a 10-meg dose. Additionally, there is a symbol that indicates when the dose knob has been pushed in and is ready to reset.*